A Channel NewsAsia commentary published on 30 August 2026 described the experience of cancer patients in Singapore who face job loss, forced leave, or reduced hours after their diagnosis. The piece raised a question that sits at the intersection of employment law and workplace management: what should an employer actually do when a member of their team is diagnosed with cancer, and what happens when they get it wrong?
For Singapore employers, the answer to that question has changed materially in the past two years. And the insurance implications, across D&O cover, employment practices liability, and group medical insurance, are worth understanding before the situation arises rather than after.
What the law now says about dismissing or disadvantaging an employee with cancer
Cancer, when it substantially limits a person's ability to carry out normal day-to-day activities, falls within the definition of disability under Singapore's Workplace Fairness Act 2024, which was passed by Parliament on 8 January 2025.
The Workplace Fairness Act prohibits adverse employment decisions based on protected characteristics. Disability is a protected characteristic. An employer who dismisses an employee because of their cancer diagnosis, forces them to take unpaid leave against their wishes, reduces their hours without agreement, or denies them a promotion because of their health condition is making an employment decision based on a protected characteristic. That is a civil contravention under the Act.
The penalties are significant. For serious civil contraventions, including retaliatory dismissals and discriminatory dismissals, the court may impose civil penalties of up to S$50,000 for a first order and up to S$250,000 for subsequent orders against a corporate employer, according to Allen and Gledhill's analysis of the Workplace Fairness Act published January 2025. For individual officers of the company, the Act provides for personal civil liability.
The Act is expected to take effect by end-2027 with phased implementation, according to Fragomen's February 2026 update on Singapore's workplace fairness legislation. But the Tripartite Guidelines on Fair Employment Practices, which the Act builds on, already create expectations around how employers handle employees with health conditions. Getting this wrong now, before full enforcement, still creates reputational and legal exposure.
The Tripartite Advisory on Reasonable Accommodations for Persons with Disabilities, published alongside the Act, requires employers to consider flexible work arrangement requests from employees with disabilities fairly and on a case-by-case basis. Requests can only be rejected on business-related grounds, and where rejected, the employer must inform the employee in writing with the reasons. An employer who refuses a flexible arrangement request from a cancer patient without following this process, or who imposes a reduction in hours without the employee's consent, creates an employment claim risk under the existing Employment Act and, once WFA is in force, under the new statute.
The D&O and employment practices dimension: personal liability for directors and managers
Most Singapore employers understand that a wrongful dismissal claim can be brought against the company. Fewer have considered that the individual director or officer who made or approved the decision can face personal liability separately from the company.
The Workplace Fairness Act specifically provides that officers of the company may have personal civil liability for contraventions under the new laws, according to Bird and Bird's commentary on the legislation. A director who instructs HR to terminate a cancer patient, knowing the decision is grounded in the employee's health condition, is not automatically protected by the corporate structure. The civil penalty and the legal costs of defending that position fall on the individual.
This is where two distinct insurance products become relevant, and it is worth being clear about what each covers.
Directors and Officers (D&O) insurance covers the personal legal costs of directors and officers where claims are made against them in their individual capacity as decision-makers. When a director faces personal civil liability under the WFA for a discriminatory dismissal decision, D&O cover responds to the legal costs of defending that claim and any civil penalty awarded against the director personally. The policy covers past, present, and future directors and officers, and extends to shadow directors: individuals who are not formally appointed as directors but whose instructions the board habitually follows.
D&O insurance is personal cover for the individual. It does not cover the company as an entity, and it does not automatically cover every employment-related claim directed at the organisation as a whole.
Employment Practices Liability (EPL) insurance covers the company's legal defence costs and any compensation award arising from employment practice claims brought against the company as an entity, including wrongful dismissal, discrimination, harassment, and failure to accommodate a disability. In Singapore, EPL cover is available as a separate insurance component and is not a standard feature of every D&O policy. Whether EPL cover is available and how it is structured depends on the specific policy the employer holds.
The two products address two different parties in the same event. A discriminatory dismissal of a cancer patient may give rise to a personal claim against the director who made the decision, and separately to a company-level claim for the employment practice itself. D&O cover responds to the first. EPL cover responds to the second. Neither automatically covers the other.
Two specific scenarios make this concrete.
A director decides to terminate an employee who has taken extended medical leave for cancer treatment, concluding that the employee is no longer able to perform the role. If that decision is later found to be a discriminatory dismissal under the WFA, the director faces personal civil liability. D&O insurance covers the legal costs of defending that personal claim and any civil penalty awarded against the director.
The same dismissal may also give rise to a company-level claim for unfair employment practice. The company's legal defence costs and any compensation awarded to the employee are addressed by EPL cover, not by the D&O policy.
For a Singapore employer whose directors are making employment decisions with WFA implications, confirming that both dimensions of the insurance programme are in place is the right question to ask at the next renewal.
You can read more about our D&O cover on the products page.
The group medical insurance dimension: what happens to benefits during and after cancer treatment
A cancer diagnosis creates a series of specific group medical insurance questions that most HR managers have not thought through in advance. Understanding how the policy works in each of the following scenarios is more useful before the situation arises than at the point of the first claim.
The per disability limit. Most Group Hospital and Surgical (GHS) policies in Singapore impose a per disability limit: the maximum the policy will pay for a single disability, which in policy terms means a single illness or injury episode including all related treatment. A cancer diagnosis is typically treated as one disability, and all treatment arising from it, including chemotherapy, radiation, surgery, specialist consultations, and follow-up imaging, counts toward that single limit.
Cancer treatment is sustained and multi-session. For a patient whose treatment extends across many months, the per disability limit can be reached well before the end of the policy year. Once the limit is exhausted, costs fall to the employee personally, to their Integrated Shield Plan if they hold one, or to MediSave and MediShield Life. The employer's group policy does not top up automatically.
There is a second dimension to large claims that employers often overlook: the impact on renewal pricing. Most Singapore group medical insurance is renewed on a claims-based or experience-rated basis for groups of a sufficient size. A significant cancer claim during the policy year is recorded in the group's loss ratio. At renewal, the insurer prices the next year based in part on that claims experience. A group that has had one or more large cancer claims may see a materially higher renewal premium, regardless of whether the affected employee is still with the company. The claim has already been made, and the loss ratio reflects it.
This does not mean employers should think twice about supporting an employee's treatment. It does mean that HR and finance should understand the renewal mechanics of their group policy so that a premium increase at renewal is not a surprise.
We covered the per disability limit and renewal dynamics in more detail in our post on The Chronic Illness Gap in Singapore Group Medical Insurance.
The part-time reduction. If the employer reduces a cancer patient from full-time to part-time to accommodate their treatment schedule, the employee's status under the group medical policy needs to be checked. Many group policies define eligible employees as full-time employees working a minimum number of hours per week. A part-time employee whose hours fall below that threshold may no longer be within the policy's definition of an eligible insured. The employer may believe the employee is still covered. The employee may believe the same. The policy wording may say otherwise.
The medical leave exhaustion. Under the Employment Act, a Singapore employee is entitled to paid hospitalisation leave of up to 60 days per year. A cancer patient undergoing active treatment can exhaust this entitlement within months. Once paid hospitalisation leave is exhausted, additional absence is either unpaid leave or leave without pay, depending on what the employment contract provides. The group medical policy covers treatment costs. It does not cover income replacement during extended unpaid leave. That is a personal financial exposure for the employee that no employer-sponsored group benefit addresses.
The return-to-work coverage question. An employee who has been on extended medical leave and returns to active employment should be reinstated to the group medical policy on their return. Where the employer changed group medical insurers during the employee's absence, the new insurer's pre-existing condition provisions or waiting periods may apply to cancer-related treatment from the point of the policy switch. Confirming the continuity position with the insurer before the employee returns is a step that avoids a coverage dispute at claim time.
The employee who leaves employment during treatment. An employee who is retrenched, who resigns, or whose employment ends during cancer treatment loses the employer-sponsored group medical benefit on the date of termination. Their personal Integrated Shield Plan, if they hold one, continues independently of their employment. An employee who does not hold a personal IP loses all hospitalisation coverage beyond MediShield Life at the point employment ends. Communicating this clearly to employees as part of an honest benefits briefing is in the employer's interest as well as the employee's.
You can read more about our Group Medical cover on the products page, and about the personal insurance gap in our post on Cancer in Younger Adults and the Employee Benefits Gap.
What employers should have in place
For a Singapore employer who wants to handle a cancer diagnosis in the team correctly, on both the legal and the insurance dimensions, three practical steps apply.
Confirm that the insurance programme covers both personal D&O liability and company-level EPL. D&O insurance covers the personal exposure of individual directors where they face claims in their own capacity. EPL cover addresses company-level employment practice claims. The two are distinct. An employer who holds only one without the other has a gap. Given the personal liability provisions of the Workplace Fairness Act, both are worth reviewing at the next renewal.
Read the group medical policy's definition of eligible employees. Confirm whether part-time employees are covered, what the per disability limit is, and what happens to cover during extended medical leave and at the point of return. These are the three most common gaps that surface when a serious illness claim arises.
Brief HR on the Workplace Fairness Act obligations. Flexible work arrangement requests must be considered fairly and rejected only on documented business grounds. Dismissal or adverse employment action based on a health condition is a civil contravention. The process for handling both situations needs to be documented before a situation arises, not improvised when it does.
If you are a Singapore employer and would like to understand how your D&O, EPL, and group medical programme addresses these scenarios, we would be glad to work through it with you.
This article provides general information only. It is not insurance or legal advice. The Workplace Fairness Act 2024 was passed by the Singapore Parliament on 8 January 2025 and is expected to take effect by end-2027 with phased implementation, according to Fragomen February 2026 and Allen and Gledhill January 2025 published guidance. Civil penalty figures sourced from Lexology analysis of the Workplace Fairness Act published February 2025. The Tripartite Advisory on Reasonable Accommodations for Persons with Disabilities is sourced from MOM and Paul Hastings Singapore employment law update. Personal liability provisions sourced from Bird and Bird commentary on the Workplace Fairness legislation. Employers should seek qualified legal and HR advice on their specific obligations under the Workplace Fairness Act and Employment Act before making employment decisions involving employees with health conditions. Policy availability, terms, conditions, and exclusions vary by insurer and product, and cover is subject to the full policy wording. Please contact TZY CO for advice on your specific situation.